News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Corden Pharma Colorado Receives Potent Compound Safety Certification Approval From SafeBridge Consultants, Inc.®


1/27/2014 9:45:51 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BOULDER, Colo.--(BUSINESS WIRE)--CordenPharma Colorado (CPC), an Active Pharmaceutical Ingredient (API) manufacturing facility in Boulder, Colorado, announces receipt of approval for the "Potent Compound Safety Certification" by SafeBridge® Consultants, Inc. (SafeBridge), headquartered in Mountain View, California. By meeting the criteria established under the SafeBridge program, CordenPharma Colorado is deemed competent and proficient in the safe handling of potent APIs and compounds of unknown toxicity and potency. The SafeBridge Potent Compound Safety Certification of CordenPharma Colorado applies to specific laboratory and manufacturing areas involved in the manufacture of APIs and synthetic intermediates.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES